Investment Centers of America’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-67,870
Closed -$6.04M 5
2017
Q3
$6.04M Sell
67,870
-4,598
-6% -$350K 0.44% 55
2017
Q2
$5.27M Sell
72,468
-3,906
-5% -$263K 0.4% 63
2017
Q1
$5.03M Buy
76,374
+810
+1% +$50.9K 0.39% 65
2016
Q4
$4.73M Buy
75,564
+9,323
+14% +$569K 0.4% 64
2016
Q3
$4.17M Buy
66,241
+3,201
+5% +$207K 0.43% 56
2016
Q2
$3.88M Sell
63,040
-2,428
-4% -$148K 0.44% 56
2016
Q1
$3.76M Buy
65,468
+19,967
+44% +$1.11M 0.42% 63
2015
Q4
$2.7M Buy
45,501
+3,235
+8% +$186K 0.35% 72
2015
Q3
$2.28M Buy
42,266
+2,747
+7% +$179K 0.35% 76
2015
Q2
$2.65M Buy
39,519
+322
+0.8% +$21K 0.4% 72
2015
Q1
$2.3M Buy
39,197
+10,718
+38% +$648K 0.34% 84
2014
Q4
$1.88M Sell
28,479
-4,518
-14% -$285K 0.41% 66
2014
Q3
$1.92M Buy
32,997
+6,553
+25% +$364K 0.34% 81
2014
Q2
$1.5M Sell
26,444
-6,786
-20% -$356K 0.34% 83
2014
Q1
$1.46M Buy
33,230
+15,642
+89% +$791K 0.3% 91
2013
Q4
$774K Sell
17,588
-15,642
-47% -$769K 0.37% 76
2013
Q3
$1.46M Buy
33,230
+9,238
+39% +$410K 0.29% 92
2013
Q2
$980K Buy
+23,992
New +$1.05M 0.27% 108

Other funds holding ABBV

Investment Centers of America's ABBV Position: Q4 2017 in Review

Investment Centers of America sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 67,870 shares — an estimated $6.04M sold.

Investment Centers of America first reported a position in ABBV in Q2 2013 and held it in 18 quarters. The position peaked at $6.04M in Q3 2017. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Investment Centers of America reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 67,870 AbbVie shares in Q4 2017, an estimated $6.04M.
  • Investment Centers of America first reported a position in AbbVie in Q2 2013 and held it in 18 quarters.
  • Investment Centers of America's AbbVie position peaked at $6.04M in Q3 2017.
  • 2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.